Product
TNF Inhibitor
Aliases
Adalimumab, Etanercept
Name
ENBREL
INN Name
etanercept
FDA Approved
Yes
5 clinical trials
2 organizations
4 indications
1 document
Indication
Rheumatoid ArthritisIndication
ulcerative colitisIndication
Psoriatic ArthritisIndication
SpondyloarthritisClinical trial
A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid ArthritisStatus: Recruiting, Estimated PCD: 2024-12-27
Clinical trial
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid ArthritisStatus: Active (not recruiting), Estimated PCD: 2025-04-14
Clinical trial
An Early Combined Microbiota and Metabolic Signature in Ulcerative Colitis Patients Predict the Clinical Success of Anti-inflammatory TherapyStatus: Recruiting, Estimated PCD: 2025-01-31
Clinical trial
The SARS-CoV-2 Vaccine Response and Safety in Rheumatology Patients and the Influence of Temporary Interruptions in Immunomodulatory TherapyStatus: Recruiting, Estimated PCD: 2024-02-29
Clinical trial
Efficacy of a Sequential Treatment Strategy in Rheumatoid Arthritis. A Randomized Controlled Trial With an Independent Efficacy Assessor.Status: Recruiting, Estimated PCD: 2024-11-01
Document
DailyMed Label: ENBRELOrganization
A-S Medication SolutionsOrganization
Immunex Corporation